Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carotegrast methyl in active ulcerative colitis
NCT06897150Phase 4Completed
- Start
- Jun 2022
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of firategrast in ulcerative colitis (UC). Started Jun 2022; status: completed.
02
Drugs
firategrast
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06897150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06897150.